American Oriental Bioengineering first-quarter revenue increases 16.

, , a pharmaceutical company focused on improving health through the development, produce and commercialization of a wide range of prescription and over-the-counter products, today announced financial outcomes for the first quarter ended March 31, 2010. First Quarter 2010 Financial Performance Income in the first one fourth of 2010 increased 16.7 percent year over year to $53.7 million from $46.1 million, reflecting continued demand for the Company’s core prescription and OTC pharmaceutical items. – – Revenue from pharmaceutical products increased 17.8 percent to $40.9 million from $34.7 million in the first quarter of 2009, powered by improved demand for the Shuanghuanglian Injection Powder, BOKE and CCXA pharmaceutical items, and also the newly-launched items such as for example YuYeQingHuo Capsules.But the advice provided by the authors could unnecessarily frighten women who have consumed some caffeine during being pregnant. Pregnant women should reduce their intake of caffeine, but should never replace it with unhealthy alternatives such as alcoholic drinks or carbonated drinks filled with sugar, they add.. Appropriators focus on omnibus spending expenses quietly In the news Also, the Senate approves legislation to reauthorize federal intervention and research activities to lessen the rate of premature births.